CT
Celldex Therapeutics Inc
🇩🇪XSTU.TCE2GermanyHealthcare
€33.08EURdown -0.58 (-1.72%)OpenEnd of day7:28 PM
Price€33.08-0.58 (-1.72%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US15117B2025
- CUSIP
- Not reported
Company
- Employees
- 198
- Headquarters
- Hampton, United States
- Website
- https://www.celldex.com
- CEO
- Mr. Anthony S. Marucci M.B.A.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$3.86
- P/E LTM
- -9.64
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $112K-98.07%down year on year
- Net income
- -$300.59M-50.59%down year on year
- Gross margin
- -56,850.89%-2,138.08%down year on year
- Free cash flow
- -$241.82M-29.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.